Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    Tozuleristide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Blaze Bioscience Announces FDA Has Granted Fast Track Designation to BLZ-100
    Blaze Bioscience Announces FDA Has Granted Fast Track Designation to BLZ-100

    07 Apr 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200407005238/en/Blaze-Bioscience-Announces-FDA-Granted-Fast-Track/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    BUSINESSWIRE
    07 Apr 2020
    Share Share
    Blaze Bio posts phase 1 data for cancer-illuminating 'tumor paint'
    Blaze Bio posts phase 1 data for cancer-illuminating 'tumor paint'

    09 May 2019

    // Amirah Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/blaze-bio-posts-phase-1-data-for-cancer-illuminating-tumor-paint

    Amirah Al Idrus FIERCE BIOTECH
    09 May 2019
    Share Share
    Blaze Bioscience Announces the Publication of Phase 1 Clinical Trial Results
    Blaze Bioscience Announces the Publication of Phase 1 Clinical Trial Results

    09 May 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190509005235/en

    BUSINESSWIRE
    09 May 2019
    Share Share